• OPEN AN ACCOUNT
Indian Indices
Nifty
24,821.10 140.20
(0.57%)
Sensex
81,337.95 446.93
( 0.55%)
Bank Nifty
56,222.00 137.10
( 0.24%)
Nifty IT
35,373.25 3.20
( 0.01%)
Global Indices
Nasdaq
44,851.29 -71.64
(-0.16%)
Dow Jones
6,409.51 -0.13
(0.00%)
Hang Seng
40,625.40 -372.87
(-0.91%)
Nikkei 225
9,136.32 54.88
(0.60%)
Forex
USD-INR
86.51 0.12
(0.14%)
EUR-INR
101.58 -0.03
(-0.03%)
GBP-INR
116.22 -0.77
(-0.66%)
JPY-INR
0.59 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Laurus Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540222
INE947Q01028
84.5862053
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LAURUSLABS
94.14
47951.54
EPS(TTM)
Face Value()
Div & Yield %
9.44
2
0.13
 

Par Drugs & Chemicals standalone net profit declines 55.65% in the March 2025 quarter
May 09,2025
Net profit of Par Drugs & Chemicals declined 55.65% to Rs 1.65 crore in the quarter ended March 2025 as against Rs 3.72 crore during the previous quarter ended March 2024. Sales declined 2.15% to Rs 22.33 crore in the quarter ended March 2025 as against Rs 22.82 crore during the previous quarter ended March 2024.

For the full year,net profit declined 7.86% to Rs 13.36 crore in the year ended March 2025 as against Rs 14.50 crore during the previous year ended March 2024. Sales rose 5.57% to Rs 100.97 crore in the year ended March 2025 as against Rs 95.64 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales22.3322.82 -2 100.9795.64 6
OPM %10.8826.73 -19.3223.87 -
PBDT3.206.00 -47 21.5822.96 -6
PBT2.285.11 -55 17.9319.52 -8
NP1.653.72 -56 13.3614.50 -8